Tolvasure-15 contains Tolvaptan (15 mg) a selective vasopressin V2 receptor antagonist used primarily for the management of autosomal dominant polycystic kidney disease (ADPKD) and heart failure. By inhibiting vasopressin’s action Tolvaptan helps reduce kidney cyst growth and preserves renal function. This medication is essential for patients looking to manage symptoms and slow the progression of kidney disease ultimately improving quality of life.
Reviews
There are no reviews yet.